Search Results - Atwell, Druid C.

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report

    Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a cas... by Naqash, Abdul Rafeh, Yang, Li V, Sanderlin, Edward J, Atwell, Druid C, Walker, Paul R

    Published in Acta oncologica
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report

    Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report by McCallen, Justin D., Naqash, Abdul Rafeh, Marie, Mona A., Atwell, Druid C., Muzaffar, Mahvish, Sharma, Nitika, Amara, Suneetha, Liles, Darla, Walker, Paul R., Yang, Li V.

    Published in Acta oncologica
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report

    Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report by McCallen, Justin D, Naqash, Abdul Rafeh, Marie, Mona A, Atwell, Druid C, Muzaffar, Mahvish, Sharma, Nitika, Amara, Suneetha, Liles, Darla, Walker, Paul R, Yang, Li V

    Get full text
    Report
    Save to List
    Saved in:
  4. 4
    Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report

    Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a cas... by Naqash, Abdul Rafeh, Yang, Li V, Sanderlin, Edward J, Atwell, Druid C, Walker, Paul R

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: